Shaimaa Lashin
YOU?
Author Swipe
View article: PA15 Harlequin ichthyosis: a multidisciplinary journey from antenatal to neonatal care
PA15 Harlequin ichthyosis: a multidisciplinary journey from antenatal to neonatal care Open
Harlequin ichthyosis is a very rare genodermatosis with a birth incidence of 1 in 300 000 births and a high mortality rate of 50% (Ahmed H, O’Toole E. Recent advances in the genetics and management of harlequin ichthyosis. Paediatr Dermato…
View article: Can angiotropism and lymphovascular invasion refine the current cutaneous melanoma staging system?
Can angiotropism and lymphovascular invasion refine the current cutaneous melanoma staging system? Open
Background Several prognostic factors for primary cutaneous melanoma (PCM) have been identified, and these predict metastasis and survival, to a certain extent. We sought to determine the frequency of angiotropism (AT) and lymphovascular i…
View article: Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Open
Supplementary Figures and Tables
View article: Data from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Data from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Open
Many cancers are termed immunoevasive due to expression of immunomodulatory ligands. Programmed death ligand-1 (PD-L1) and cluster of differentiation 80/86 (CD80/86) interact with their receptors, programmed death receptor-1 (PD-1) and cyt…
View article: Data from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Data from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Open
Many cancers are termed immunoevasive due to expression of immunomodulatory ligands. Programmed death ligand-1 (PD-L1) and cluster of differentiation 80/86 (CD80/86) interact with their receptors, programmed death receptor-1 (PD-1) and cyt…
View article: Supplementary FRET Methods from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Supplementary FRET Methods from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Open
Supplementary FRET Methods
View article: Supplementary FRET Methods from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Supplementary FRET Methods from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Open
Supplementary FRET Methods
View article: Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Supplementary Figures and Tables from High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Open
Supplementary Figures and Tables
View article: Ran GTPase is an independent prognostic marker in malignant melanoma which promotes tumour cell migration and invasion
Ran GTPase is an independent prognostic marker in malignant melanoma which promotes tumour cell migration and invasion Open
Aims Ran GTPase is involved in nucleocytoplasmic shuttling of proteins and is overexpressed in several cancers. The expression of Ran in malignant melanoma (MM) and its functional activity have not been described and were investigated in t…
View article: Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma
Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma Open
Many cancers are termed immuno-evasive due to expression of immuno-modulatory ligands. Programmed death ligand-1 (PD-L1) and cluster of differentiation 80/86 (CD80/86) interact with their receptors, programmed death receptor-1 (PD-1) and c…